(redirected from estrogen receptor status)
Also found in: Dictionary, Thesaurus, Medical, Legal.


Law the legal standing or condition of a person


  1. any stable position within a social system associated with specific expectations, rights and duties. 'Status’ in this sense is equivalent to ROLE, although it is the latter term which has the wider currency.
  2. the positive or negative honour, prestige, power, etc., attaching to a position, or an individual person, within a system of SOCIAL STRATIFICATION (often referred to as social status).
Both conceptions derive from forms of society in which individual social locations were relatively fixed (see ASCRIBED STATUS, MAINE), for example by religion or by law (see CASTE, ESTATE). In modern societies status positions tend to be more fluid. See also STATUS GROUP, CLASS, STATUS AND PARTY, SOCIOECONOMIC STATUS, STATUS CONSISTENCY AND INCONSISTENCY.



in the Hamito-Semitic languages, a grammatical category of the noun that determines whether the noun is definite and whether it has a relationship with other parts of the sentence; in particular, whether the noun has a genitival attribute. A noun’s status also indicates possession, as in Arabic - i(”my”), and demonstrativeness, as in Somali -k-an (”this,” masculine) and -t-an (”this,” feminine). The category of status exists in the Semitic, Coptic, Berber, Cushitic and Chad languages. It is expressed by means of suffixes, prefixes, internal inflection, and distinctions in declensional paradigms.


D’iakonov, I. M. Semito-khamitskie iazyki. Moscow, 1965.
Tucker, A. N., and M. A. Bryan. The Non-Bantu Languages ofNorth-Eastern Africa. London, 1966.
References in periodicals archive ?
Estrogen receptor status is a breast cancer patient's single most powerful predictor of outcome.
SAN ANTONIO -- Estrogen receptor status flip-flops in 1 in 3 breast cancer patients when the primary tumor progresses to recurrence or distant metastasis, and HER2 status changes in 1 in 10, according to a Swedish study.
Re: Tamoxifen may be an effective treatment for BRCA1-related breast cancer irrespective of estrogen receptor status.
In the case of CYP2D6 testing, a limited number of retrospective studies have produced conflicting results, and are beset with methodological problems, such as small sample sizes, heterogeneity arising from differing study designs, selection criteria, uncontrolled confounding factors, and the misclassification of patients' estrogen receptor status.
The researchers write that this association did not differ "appreciably by stage, menopausal status, body mass index, or estrogen receptor status.
Black women who are diagnosed with breast cancer have a higher probability of dying from the disease than white women, regardless of their estrogen receptor status, according to research from the National Cancer Institute (NCI), part of the National Institutes of Health.

Full browser ?